Your browser doesn't support javascript.
loading
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
Fava, Carmen; Rege-Cambrin, Giovanna; Dogliotti, Irene; Cerrano, Marco; Berchialla, Paola; Dragani, Matteo; Rosti, Gianantonio; Castagnetti, Fausto; Gugliotta, Gabriele; Martino, Bruno; Gambacorti-Passerini, Carlo; Abruzzese, Elisabetta; Elena, Chiara; Pregno, Patrizia; Gozzini, Antonella; Capodanno, Isabella; Bergamaschi, Micaela; Crugnola, Monica; Bocchia, Monica; Galimberti, Sara; Rapezzi, Davide; Iurlo, Alessandra; Cattaneo, Daniele; Latagliata, Roberto; Breccia, Massimo; Cedrone, Michele; Santoro, Marco; Annunziata, Mario; Levato, Luciano; Stagno, Fabio; Cavazzini, Francesco; Sgherza, Nicola; Giai, Valentina; Luciano, Luigia; Russo, Sabina; Musto, Pellegrino; Caocci, Giovanni; Sorà, Federica; Iuliano, Francesco; Lunghi, Francesca; Specchia, Giorgina; Pane, Fabrizio; Ferrero, Dario; Baccarani, Michele; Saglio, Giuseppe.
Afiliação
  • Fava C; Department of Clinical and Biological Sciences, University of Turin, Orbassano carmen.fava@unito.it.
  • Rege-Cambrin G; Department of Clinical and Biological Sciences, University of Turin, Orbassano.
  • Dogliotti I; Department of Clinical and Biological Sciences, University of Turin, Orbassano.
  • Cerrano M; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin.
  • Berchialla P; Department of Clinical and Biological Sciences, University of Turin, Orbassano.
  • Dragani M; Department of Clinical and Biological Sciences, University of Turin, Orbassano.
  • Rosti G; Institute of Hematology "L. & A. Seràgnoli", St. Orsola University Hospital, Bologna.
  • Castagnetti F; Institute of Hematology "L. & A. Seràgnoli", St. Orsola University Hospital, Bologna.
  • Gugliotta G; Institute of Hematology "L. & A. Seràgnoli", St. Orsola University Hospital, Bologna.
  • Martino B; Azienda Ospedaliera "Bianchi Melacrino Morelli", Reggio Calabria.
  • Gambacorti-Passerini C; University Milano Bicocca, San Gerardo Hospital, Monza.
  • Abruzzese E; Haematology Unit, S. Eugenio Hospital, Rome.
  • Elena C; Hematology Hunit, Fondazione IRCCS Policlinico San Matteo, Pavia.
  • Pregno P; A.O. Città della Salute e della Scienza di Torino, Turin.
  • Gozzini A; SC Terapie Cellulari e Medicina Trasfusionale, AOU Careggi, Florence.
  • Capodanno I; Hematology, Azienda Unità Sanitaria Locale -IRCCS, Reggio Emilia.
  • Bergamaschi M; Division of Hematology 1, IRCCS AOU San Martino-IST, Genoa.
  • Crugnola M; Division of Hematology, University Hospital of Parma, Parma.
  • Bocchia M; Azienda Ospedaliera Universitaria, University of Siena, Siena.
  • Galimberti S; Hematology Department, University of Pisa, Pisa.
  • Rapezzi D; S.C. Ematologia, ASO S. Croce e Carle, Cuneo.
  • Iurlo A; Haematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
  • Cattaneo D; Haematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
  • Latagliata R; Department of Cellular Biotechnologies and Hematology, University La Sapienza, Rome.
  • Breccia M; Department of Cellular Biotechnologies and Hematology, University La Sapienza, Rome.
  • Cedrone M; UOC of Hematology, San Giovanni - Addolorata Hospital, Rome.
  • Santoro M; Hematology Unit, University of Palermo, Palermo.
  • Annunziata M; Division of Hematology, Ospedale Cardarelli, Naples.
  • Levato L; Department Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro.
  • Stagno F; Chair and Hematology Section, Ferrarotto Hospital, Catania.
  • Cavazzini F; Department of Medical Sciences -Haematology and Physiopathology of Haemostasis Section, Ferrara.
  • Sgherza N; Division of Hematology, IRCCS Ospedale Casa Sollievo Sofferenza, San Giovanni Rotondo.
  • Giai V; Division of Haematology, SS Antonio e Biagio e Cesare Arrigo Hospital, Alessandria.
  • Luciano L; Division of Hematology - Departments of Clinical Medicine and Surgery, University of Naples Federico II, Naples.
  • Russo S; Department of Internal Medicine, AOU Policlinico di Messina, Messina.
  • Musto P; IRCCS, Centro Di Riferimento Oncologico Della Basilicata, Rionero in Vulture.
  • Caocci G; Department of Medical Sciences, University of Cagliari, Cagliari.
  • Sorà F; Hematology Department, University Cattolica del Sacro Cuore - Policlinico A. Gemelli, Rome.
  • Iuliano F; Presidio Ospedaliero N. Giannetasio - Azienda ASL 3, Rossano.
  • Lunghi F; Division of Haematology and Bone Marrow Transplant, Ospedale San Raffaele IRCCS, Milan.
  • Specchia G; Division of Haematology with Transplant - Outpatients, Azienda Ospedaliero-Universitaria Policlinico Consorziale di Bari, Bari, Italy.
  • Pane F; Division of Hematology - Departments of Clinical Medicine and Surgery, University of Naples Federico II, Naples.
  • Ferrero D; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin.
  • Baccarani M; Institute of Hematology "L. & A. Seràgnoli", St. Orsola University Hospital, Bologna.
  • Saglio G; Department of Clinical and Biological Sciences, University of Turin, Orbassano.
Haematologica ; 104(8): 1589-1596, 2019 08.
Article em En | MEDLINE | ID: mdl-30819917
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica / Inibidores de Proteínas Quinases / Retirada de Medicamento Baseada em Segurança Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged / Pregnancy Idioma: En Revista: Haematologica Ano de publicação: 2019 Tipo de documento: Article País de publicação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica / Inibidores de Proteínas Quinases / Retirada de Medicamento Baseada em Segurança Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged / Pregnancy Idioma: En Revista: Haematologica Ano de publicação: 2019 Tipo de documento: Article País de publicação: Itália